VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NUVB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NUVBNuvation Bio Inc.
$4.16$1.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNUVBQuarterly Financials

Nuvation Bio Inc. (NUVB) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Nuvation Bio Inc. (NUVB) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

NUVB Income Statement

Quarterly statement

NUVB Income Statement

Nuvation Bio Inc. (NUVB) annual income statement — 8-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue44.95M31.69M83.23M41.87M13.12M4.83M3.08M5.71M727K1.44M0000000000
Revenue Growth %242.61%555.64%2598.7%633.06%1704.68%236.79%--------------
Cost of Goods Sold11.93M911K5.62M423K3.35M2.58M2.09M4.22M1.51M1.35M0000000000
COGS % of Revenue26.54%2.88%6.75%1.01%25.53%53.3%67.9%73.82%208.39%93.87%----------
Gross Profit33.02M30.78M77.61M41.44M9.77M2.26M990K1.5M-788K88K0000000000
Gross Margin %73.46%97.13%93.25%98.99%74.47%46.7%32.1%26.18%-108.39%6.13%----------
Gross Profit Growth %237.96%1263.58%7739.6%2672.04%1339.97%2464.77%--------------
Operating Expenses75.23M81.81M73.73M75.48M66.2M65.85M59.99M55.44M47.31M470.47M20.2M20.83M26.34M26.13M26.52M24.34M29.34M37.87M28.19M29.61M
OpEx % of Revenue167.36%258.19%88.59%180.29%504.61%1362.42%1945.33%970.71%6507.98%32785.57%----------
Selling, General & Admin42.55M42.59M38.31M40.33M37.36M38.48M35.39M26.14M19.58M16.16M7.36M5.48M7.78M7.54M7.73M7.46M8.04M8.95M7.46M7.61M
SG&A % of Revenue94.67%134.41%46.03%96.32%284.75%796.28%1147.63%457.68%2693.54%1125.85%----------
Research & Development32.68M30.66M35.05M34.3M28.85M27.36M24.6M29.3M27.73M454.32M12.84M15.35M18.56M18.59M18.79M16.87M21.29M28.92M20.73M22M
R&D % of Revenue72.7%96.76%42.11%81.92%219.86%566.15%797.7%513.03%3814.44%31659.72%----------
Other Operating Expenses01000K375K856K0000010000000000
Operating Income-42.21M-51.04M3.88M-34.04M-56.43M-63.59M-59M-53.94M-48.1M-470.38M-20.2M-20.83M-26.34M-26.13M-26.52M-24.34M-29.34M-37.87M-28.19M-29.61M
Operating Margin %-93.9%-161.06%4.66%-81.3%-430.14%-1315.73%-1913.23%-944.53%-6616.37%-32779.44%----------
Operating Income Growth %25.2%19.74%106.58%36.9%-17.32%86.48%-192.11%-158.95%-82.62%-1700.1%23.84%14.4%10.22%31%5.93%17.81%-28.73%-85.33%-37.63%-115.06%
EBITDA-41.63M-50.5M4.42M-33.5M-55.9M-63.23M-58.69M-53.72M-47.94M-470.14M-20.14M-20.78M-26.28M-26.07M-26.46M-24.29M-29.28M-37.82M-28.15M-29.57M
EBITDA Margin %-92.62%-159.37%5.31%-80.01%-426.07%-1308.36%-1903.18%-940.69%-6594.09%-32762.44%----------
EBITDA Growth %25.52%20.14%107.53%37.65%-16.61%86.55%-191.42%-158.58%-82.39%-1703.03%23.9%14.45%10.24%31.06%5.97%17.86%-28.88%-85.47%-37.61%-115.17%
D&A (Non-Cash Add-back)578K536K536K539K534K356K310K219K162K244K58K55K55K56K56K49K56K48K46K43K
EBIT-35.78M-56.08M12.11M-29.92M-55.29M-58.59M-53.18M-49.36M-41.09M-462.36M-14.79M-20.83M-19.65M-20.64M-26.52M-24.34M-29.34M-37.87M-28.19M-29.61M
Net Interest Income41K-2.16M-1.6M-1.38M-501K4.36M5.27M5.97M6.61M7.01M7.13M7.02M6.52M6.09M4.98M3.52M2.13M841K958K902K
Interest Income6.16M4.6M5.11M5.3M6.03M4.78M5.32M6.06M6.73M7.14M7.13M7.02M6.52M6.09M4.98M3.52M2.13M841K958K902K
Interest Expense6.12M6.76M6.71M6.67M6.53M421K54K89K120K132K0000000000
Other Income/Expense311K-11.8M1.52M-2.56M642K4.58M5.77M4.5M6.89M7.89M5.41M7.04M6.69M5.49M4.79M3.49M2.13M3.01M6.9M4.47M
Pretax Income-41.9M-62.84M5.4M-36.59M-55.79M-59.01M-53.24M-49.45M-41.21M-462.49M-14.79M-13.79M-19.65M-20.64M-21.73M-20.84M-27.2M-34.86M-21.29M-25.13M
Pretax Margin %-93.21%-198.31%6.48%-87.4%-425.24%-1220.92%-1726.2%-865.79%-5668.5%-32229.41%----------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-41.9M-62.84M5.4M-36.59M-55.79M-59.01M-53.24M-49.45M-41.21M-462.49M-14.79M-13.79M-19.65M-20.64M-21.73M-20.84M-27.2M-34.86M-21.29M-25.13M
Net Margin %-93.21%-198.31%6.48%-87.4%-425.24%-1220.92%-1726.2%-865.79%-5668.5%-32229.41%----------
Net Income Growth %24.9%-6.5%110.14%25.99%-35.38%87.24%-259.9%-258.63%-109.73%-2140.76%31.92%33.86%27.77%40.79%-2.03%17.06%-23.77%-80.3%-4.37%-89.26%
Net Income (Continuing)-41.9M-62.84M5.4M-36.59M-55.79M-59.01M-53.24M-49.45M-41.21M-462.49M-14.79M-13.79M-19.65M-20.64M-21.73M-20.84M-27.2M-34.86M-21.29M-25.13M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.12-0.180.01-0.11-0.16-0.17-0.16-0.15-0.15-1.89-0.07-0.06-0.09-0.09-0.10-0.10-0.12-0.16-0.10-0.12
EPS Growth %25%-5.88%108.94%26.67%-6.67%91.01%-128.57%-138.1%-66.67%-2000%29.51%37%25%43.75%0.7%16.67%-9.09%-77.78%16.67%-20.72%
EPS (Basic)-0.12-0.180.02-0.11-0.16-0.17-0.16-0.15-0.15-1.89-0.07-0.06-0.09-0.09-0.10-0.10-0.12-0.16-0.10-0.12
Diluted Shares Outstanding351.86M348.77M377.52M344.34M342.39M340.75M338.61M336.93M273.56M244.74M219.05M218.91M218.94M218.85M218.74M218.5M218.3M216.6M213.41M202.49M
Basic Shares Outstanding351.86M348.77M347.33M344.34M342.39M340.75M338.61M336.93M273.56M244.74M219.05M218.91M218.94M218.85M218.74M218.5M218.3M216.6M213.41M202.49M
Dividend Payout Ratio--------------------